MicroPort Sorim CRM, a Chinese medical device company, has announced that it has received market approval from the National Medical Products Administration (NMPA) for its PLATINIUM series implantable cardioverter defibrillator (ICD). This marks a significant milestone as the PLATINIUM series becomes the first domestically developed ICD in China. The approved product series encompasses two model specifications: the dual chamber PLATTINUM DR 1540 and the single chamber PLATTINUM VR 1240.
The NMPA’s approval of the PLATINIUM series signifies a new era for domestic products in the high-energy defibrillation segment of the cardiac rhythm management market. This development highlights the growing capabilities of Chinese medical device manufacturers to compete in specialized niches that were traditionally dominated by international companies.
The introduction of the PLATINIUM series is expected to enhance patient access to advanced cardiac care solutions and contribute to the advancement of medical device technology in China.- Flcube.com
